GRTS - グリットスト―ン・オンコロジ― （Gritstone Oncology Inc.） グリットスト―ン・オンコロジ―GRTSのチャート
GRTSの企業情報
| symbol | GRTS |
|---|---|
| 会社名 | Gritstone Oncology Inc （グリットスト―ン・オンコロジ―） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Biological Products (No Diagnostic Substances) |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 Gritstone Oncology Inc. is an immuno-oncology company that develops tumor-specific cancer immunotherapies to fight multiple cancer types. The Company focuses to identify and deploy therapeutic neo-antigens from individual patients' tumors to develop treatments for lung cancer. It provides Gritstone EDGE which is a tumor-specific neo-antigen (TSNA) prediction platform that predicts the presence of a patient’s TSNA on tumor cells. It also develops and manufactures a patient-specific therapeutic to direct a robust thymus (T) cell response to those TSNA predicted to be presented on the patient’s tumor. In its GRANITE-001 product candidate each of the viral prime and RNA boost immunizations contain a patient-specific set of predicted TSNA and the viral prime and RNA boost in its SLATE product candidate series contains a fixed TSNA cassette that is designed for the subset of patients with tumor neoantigens. グリットスト―ン・オンコロジ―は米国の新薬開発企業。AI技術を利用したがん治療のパイプラインを開発。各患者の腫瘍の個々の性質に焦点を当て、同社のAIプラットフォ―ムGritstone EDGEの予測能力を組み合わせることにより、複数のタイプのがんと闘う患者向けに個人化免疫療法を開発、提供する。本社所在地はカリフォルニア州エメリ―ビル。 Gritstone bio, Inc., a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone develops its products by leveraging two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGETM, which is designed to predict antigens that are presented on the surface of cells, such as tumor or virally-infected cells, that can be seen by the immune system; and, second, the ability to develop and manufacture potent immunotherapies utilizing these antigens to potentially drive the patient’s immune system to specifically attack and destroy disease-causing cells. The company’s lead oncology programs include an individualized neoantigen-based immunotherapy, GRANITE, and an “off-the-shelf” shared neoantigen-based immunotherapy, SLATE, which are being evaluated in clinical studies. Within its infectious disease pipeline, Gritstone is advancing CORAL, a COVID-19 program to develop a second-generation vaccine, with support from departments within the National Institutes of Health (NIH), the Bill & Melinda Gates Foundation, as well as a license agreement with La Jolla Institute for Immunology. Additionally, the company has a global collaboration for the development of a therapeutic HIV vaccine with Gilead Sciences. |
| 本社所在地 | 5858 Horton Street Suite 210 Emeryville CA 94608 USA |
| 代表者氏名 | Andrew R. Allen アンドリュー・R・アレン |
| 代表者役職名 | President Chief Executive Officer Co-Founder Director |
| 電話番号 | +1 510-871-6100 |
| 設立年月日 | 42217 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | 100人 |
| url | www.gritstoneoncology.com |
| nasdaq_url | https://www.nasdaq.com/symbol/grts |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -53.00400 |
| 終値（lastsale） | 11.88 |
| 時価総額（marketcap） | 0 |
| 時価総額 | 時価総額（百万ドル） 423.78200 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 535.66500 |
| 当期純利益 | 当期純利益（百万ドル） -55.66800 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Gritstone Oncology Inc revenues was not reported. Net loss increased 98% to $28.8M. Higher net loss reflects Research and development - Bala increase from $11.5M to $23.5M (expense) General and administrative - increase of 57% to $4.3M (expense) Stock-based Compensation in SGA increase from $111K to $578K (expense). |
GRTSのテクニカル分析
GRTSのニュース
Gritstone Oncology Inc. Shares Close the Week 33.2% Lower - Weekly Wrap 2021/01/29 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 33.2% lower than it did at the end of last week. The stock is currently up 359.4% year-to-date, up 86.8% over the past 12 months, and up 27.1% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $28.24 and as low as $17.00 this week.Shares closed 3e+1% below its 52-week high and 6e+2% above its 52-week low.Trading volume this week was 49.0% lower than the 10-day average and 79.4% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 598.9% The company's stock price performance over the past 12 months lags the peer average by -32.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 324.3% Higher - Weekly Wrap 2021/01/22 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 324.3% higher than it did at the end of last week. The stock is currently up 588.1% year-to-date, up 169.5% over the past 12 months, and up 90.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Shares traded as high as $35.20 and as low as $5.90 this week.Shares closed 0% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 56.5% lower than the 10-day average and 44.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 885.5% The company's stock price performance over the past 12 months beats the peer average by 29.5%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Climb 0.2% Past Previous 52-Week High - Market Mover 2021/01/20 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed 0.2% higher than its previous 52 week high, giving the company a market cap of $962M. The stock is currently up 547.0% year-to-date, up 127.0% over the past 12 months, and up 79.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 1.1%. Trading Activity Trading volume this week was 544.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 903.5% The company's stock price performance over the past 12 months lags the peer average by -0.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 20.6% Higher - Weekly Wrap 2021/01/15 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 20.6% higher than it did at the end of last week. The stock is currently up 62.2% year-to-date, down 40.6% over the past 12 months, and down 55.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $6.58 and as low as $5.20 this week.Shares closed 4e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 29.0% lower than the 10-day average and 62.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 67.9% The company's stock price performance over the past 12 months lags the peer average by -135.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 25.4% Higher - Weekly Wrap 2021/01/06 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 25.4% higher than it did at the end of last week. The stock is currently up 30.2% year-to-date, down 33.9% over the past 12 months, and down 64.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 0.4%. Trading Activity Shares traded as high as $5.85 and as low as $3.82 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 0.1% higher than the 10-day average and 71.8% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 164.6% The company's stock price performance over the past 12 months lags the peer average by -135.1%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 33.2% Lower - Weekly Wrap 2021/01/29 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 33.2% lower than it did at the end of last week. The stock is currently up 359.4% year-to-date, up 86.8% over the past 12 months, and up 27.1% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $28.24 and as low as $17.00 this week.Shares closed 3e+1% below its 52-week high and 6e+2% above its 52-week low.Trading volume this week was 49.0% lower than the 10-day average and 79.4% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 598.9% The company's stock price performance over the past 12 months lags the peer average by -32.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 324.3% Higher - Weekly Wrap 2021/01/22 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 324.3% higher than it did at the end of last week. The stock is currently up 588.1% year-to-date, up 169.5% over the past 12 months, and up 90.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Shares traded as high as $35.20 and as low as $5.90 this week.Shares closed 0% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 56.5% lower than the 10-day average and 44.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 885.5% The company's stock price performance over the past 12 months beats the peer average by 29.5%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Climb 0.2% Past Previous 52-Week High - Market Mover 2021/01/20 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed 0.2% higher than its previous 52 week high, giving the company a market cap of $962M. The stock is currently up 547.0% year-to-date, up 127.0% over the past 12 months, and up 79.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 1.1%. Trading Activity Trading volume this week was 544.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 903.5% The company's stock price performance over the past 12 months lags the peer average by -0.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 20.6% Higher - Weekly Wrap 2021/01/15 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 20.6% higher than it did at the end of last week. The stock is currently up 62.2% year-to-date, down 40.6% over the past 12 months, and down 55.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $6.58 and as low as $5.20 this week.Shares closed 4e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 29.0% lower than the 10-day average and 62.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 67.9% The company's stock price performance over the past 12 months lags the peer average by -135.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 25.4% Higher - Weekly Wrap 2021/01/06 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 25.4% higher than it did at the end of last week. The stock is currently up 30.2% year-to-date, down 33.9% over the past 12 months, and down 64.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 0.4%. Trading Activity Shares traded as high as $5.85 and as low as $3.82 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 0.1% higher than the 10-day average and 71.8% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 164.6% The company's stock price performance over the past 12 months lags the peer average by -135.1%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 33.2% Lower - Weekly Wrap 2021/01/29 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 33.2% lower than it did at the end of last week. The stock is currently up 359.4% year-to-date, up 86.8% over the past 12 months, and up 27.1% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $28.24 and as low as $17.00 this week.Shares closed 3e+1% below its 52-week high and 6e+2% above its 52-week low.Trading volume this week was 49.0% lower than the 10-day average and 79.4% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 598.9% The company's stock price performance over the past 12 months lags the peer average by -32.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 324.3% Higher - Weekly Wrap 2021/01/22 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 324.3% higher than it did at the end of last week. The stock is currently up 588.1% year-to-date, up 169.5% over the past 12 months, and up 90.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Shares traded as high as $35.20 and as low as $5.90 this week.Shares closed 0% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 56.5% lower than the 10-day average and 44.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 885.5% The company's stock price performance over the past 12 months beats the peer average by 29.5%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Climb 0.2% Past Previous 52-Week High - Market Mover 2021/01/20 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed 0.2% higher than its previous 52 week high, giving the company a market cap of $962M. The stock is currently up 547.0% year-to-date, up 127.0% over the past 12 months, and up 79.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 1.1%. Trading Activity Trading volume this week was 544.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 903.5% The company's stock price performance over the past 12 months lags the peer average by -0.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 20.6% Higher - Weekly Wrap 2021/01/15 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 20.6% higher than it did at the end of last week. The stock is currently up 62.2% year-to-date, down 40.6% over the past 12 months, and down 55.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $6.58 and as low as $5.20 this week.Shares closed 4e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 29.0% lower than the 10-day average and 62.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 67.9% The company's stock price performance over the past 12 months lags the peer average by -135.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Gritstone Oncology Inc. Shares Close the Week 25.4% Higher - Weekly Wrap 2021/01/06 22:30:00 Kwhen Finance
Gritstone Oncology Inc. shares closed this week 25.4% higher than it did at the end of last week. The stock is currently up 30.2% year-to-date, down 33.9% over the past 12 months, and down 64.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 0.4%. Trading Activity Shares traded as high as $5.85 and as low as $3.82 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 0.1% higher than the 10-day average and 71.8% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 164.6% The company's stock price performance over the past 12 months lags the peer average by -135.1%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.